Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
UV photolysis All the UV-based experiments were performed in a UV chamber (Opsytec Dr
They'll serve different niches: CagriSema Will Dominate: Patients familiar with Wegovy brand Those wanting proven semaglutide component People with type 2 diabetes (strong REIMAGINE data) Earlier availability (mid-2027) Retatrutide Will Dominate: Patients needing maximum weight loss (BMI 40) Those with multiple complications (OA + OSA + obesity) People who failed CagriSema Willingness to wait for highest efficacy Tirzepatide (Zepbound) Will Remain Relevant: Already available NOW Proven safety with 22.5% weight loss Lower cost than either new option Established insurance coverage The High-Dose CagriSema Wildcard Novo Nordisk announced plans for CagriSema 2.4mg/7.2mg trials starting late 2026tripling the cagrilintide dose
Whether or not that framing fully resolves the regulatory picture, it is the lens he uses for everything that follows
TB-500 Standard loading + maintenance cycle: 4 weeks at full dose (2x/week), then 4 weeks maintenance at half dose (1x/week)
Ill go into each of these treatments in more detail in future articles and videos, but heres a quick summary
)
)
)
